Tag: Peru

Logistics Insurance Market Size Worth $61.55 Billion By 2025

The global logistics insurance market is anticipated to reach USD 61.55 billion by 2025, according to a new report by Grand View Research, Inc. The increasing foreign direct investment, establishment of free trade zones, and increasing globalization has resulted in the rapid growth of the transportation industry in the emerging countries. The logistics hubs and trade routes are gradually shifting toward the emerging market. Privatization of the transportation industry has further spurred the industry growth in China, Turkey, and India.

The adoption of digital technologies enables the company to tap new opportunities for additional premiums, better risk selection, increasing governance, and improved customer experience. Insurers across the globe are implementing newer technologies and adopting cloud- and mobile-based technologies to tap the growing demand in the emerging markets. Through various distribution channels, the insurance companies are modernizing the legacy applications.

The insurance companies are implementing mobility as a part of the business strategy, owing to the increasing usage of smartphones in both developed and emerging markets. Customers can easily request a policy quote, calculate premium, locate insurance agent, and store the policy data with the advent of the mobile apps.

The insurance industry comprises of structured and unstructured data. Big data analytics plays a vital role in the insurance industry that delivers significant Return on Investment (ROI) and cost savings. The rise in digital integration and digital customer relationship management is likely to spur the market demand over the forecast period.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/logistics-insurance-market

Further key findings from the report suggest:

  • The increasing adoption of cloud- and mobile-based technologies to improve the customer experience
  • The transportation industry is anticipated to witness a significant growth with a CAGR of over 3.5% over the projected period
  • The maritime industry is anticipated to dominate the market in terms of revenue
  • The Asia Pacific region is anticipated to dominate the market in terms of growth rate over the forecast period
  • The rising financial asset and real estate values in the region are enabling the companies to have a higher premium volume
  • The market posesa rising competition that enable insurers to invest more in technological advancement to enhance the customer experience
  • The key players in the logistics insurance market include Integrity Transportation Insurance (U.S.), Liberty Mutual Insurance (U.S.), Peoples Insurance Agency (U.S.)

Excipients Market Size Worth $6.9 Billion By 2025

The global excipients market size is expected to reach USD 6.9 billion by 2025, expanding at a CAGR of 6.02% from 2017 to 2025, according to a new report by Grand View Research, Inc. Globally increasing reach of generic medicines has been a major factor driving market growth. In addition, rising demand for newer excipients owing to the advantages of drug delivery and stability has led to the growth of the market. 

Excipients are essential components for the improvement of overall pharmaceutical activity and performance, both of which directly impact the characteristics of pharmaceutical formulations. An excipient in the right proportion can improve the shelf life and bioavailability of a formulation. These can also be used in drug delivery mechanisms such as sustained release and rapid release drugs.

Polymers were the largest product category in 2016 and are expected to maintain a comparatively moderate growth rate over the forecast period. Microcrystalline cellulose was the leading polymer in this category, accounting for a share of over 26.0% in 2016.

Sugars are expected to observe the fastest growth over the  coming years, exhibiting an estimated CAGR of 5.1% from 2017 to 2025. Sugars can play an instrumental role in increasing solubility, taste masking, dissolution, and drug delivery, which can drive its market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/excipients-market-analysis

Further key findings from the report suggest:

  • The global excipients demand exceeded 600,000 tons in 2016 and is expected to grow at a moderate rate from 2017 to 2025
  • Owing to high market demand, polymer excipients accounted for the largest revenue share in 2016 and the segment can be anticipated to dominate the market for the coming years as well
  • The global demand for sugars excipients was valued at over USD 1 billion in 2016 and is anticipated to witness significant growth over the coming years
  • The Europe polymers market was pegged at 74,000 tons in 2015 and is estimated to reach a total volume of over 100,000 tons by 2025
  • The market in Asia Pacific is projected to witness substantial growth over the course of the forecast period thanks to several development projects undertaken across major economies, especially in newer excipients markets. The regional market is expected to register a CAGR of 6.63% from 2017 to 2025
  • Key market participants include Eastman Chemical Corporation; P&G Chemicals; Avantor Performance Materials, LLC; Huntsman Corporation; BASF SE; Ashland Inc.; FMC Corporation; Roquette; Colorcon Inc.; Lubrizol Corporation; Valeant; JRS Pharma; Shin-Etsu Chemical Co., Ltd.; DFE Pharma; and Finar Limited.

Catheter Market Size Worth $77.7 Billion By 2026

The global catheter market size is expected to reach USD 77.7 billion by 2026 registering a CAGR of 9.7%, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases and supportive insurance policies are some of the prime factors boosting the market growth. Presence of multi-national manufacturers and improving medical facilities, especially across developing regions, are also anticipated to propel the market growth over the forecast period.

As per the statistics published by the WHO, chronic diseases is anticipated to contribute to 73% of all deaths and 60% of the global burden of disease by 2020. The rise in geriatric population has also led to increase in number of hospitalizations and surgeries anticipating the market growth. Catheters have undergone technological advancements; for instance, miniaturized products and introduction of antimicrobial catheters to reduce associated infections. Wide usage of minimally invasive surgeries is expected to favor the market growth.

Rising awareness about catheters has in turn boosted their demand. In addition, increasing number of midscale catheter manufacturers gaining a higher market share is expected to promote the market growth. Furthermore, rise in funding by various government bodies and medical device manufacturers for R&D will boost the market growth. However, requirement of intensive capital for the development of advanced devices may obstruct market development.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis

Further key findings from the study suggest:

  • The cardiovascular product segment led the market in 2018 owing to increase in the number of patients suffering from chronic Cardiovascular Diseases (CVDs)
  • Specialty catheters is expected to be the fastest-growing product segment over the forecast period due to rising prevalence of target diseases and demand for minimally invasive procedures
  • Asia Pacific is anticipated to witness the fastest CAGR from 2019 to 2026 owing to rising cases of kidney and cardiovascular diseases, improving medical facilities, and supportive insurance policies
  • Some of the key companies in the global catheter market are Medtronic Plc.; Convatec Corp.; Smiths Medical, Inc.; Boston Scientific Corp.; and Coloplast A/S
  • The market is price-sensitive with many small-, medium-, and large-scale companies. Key companies focus on product bundling strategies
  • Strategic partnerships between the manufacturers and the healthcare establishments intensify the market competition

Dental Equipment Market Worth $10.47 Billion By 2025

The global dental equipment market size is expected to reach USD 10.47 billion by 2025, according to a report published by Grand View Research, Inc. It is anticipated to expand at a lucrative CAGR of 4.5% over the forecast period. Key factors attributed to the growth include increasing demand for dental procedures owing to prevalence of dental disorders and rising awareness and demand for preventive, restorative, and surgical services for dental care.

Moreover, favorable government initiatives regarding dental hygiene is also a significant factor responsible for driving the market. Due to increasing number of initiatives, there is an increase in awareness regarding dental hygiene leading to increasing adoption of dental treatments, which in turn is anticipated to drive the market for dental equipment over the forecast period.

Dental equipment are classified on the basis of product into dental radiology, dental lasers, systems and parts, laboratory machines, hygiene equipment, and others. The systems and parts segment held the leading market share of 39.9% in 2018 and is anticipated to grow at a lucrative pace over the forecast period. The segment is further classified into instrument delivery systems, vacuums and compressors cone beam CT systems, cast machines, furnace and ovens, CAD/CAM, and electrosurgical equipment. The CAD/CAM sub-segment led in 2018 owing to the technological superiority of these equipment over traditional die casting techniques.

North America led with a market share of 29.6% in 2018. Some of the key reasons attributed to the high share include technological advancements, rising demand for dental surgeries, growing geriatric population, and increasing number of dentists and dental clinics. On the other hand, Asia Pacific is expected to expand at the fastest CAGR of 4.9% over the forecast period. Constantly developing healthcare infrastructure and increasing healthcare expenditure coupled with the presence of high unmet medical needs are expected to serve this market as high-impact rendering drivers.

Few significant companies venturing in the market include, Denstply International Inc.; A-Dec Inc.; Planmeca Oy; Sirona Dental Systems Inc.; Patterson Companies Inc.; Straumann; GC Corporation; Carestream Health Inc.; Biolase Inc.; Danaher Corporation; and 3M.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/dental-equipment-market

Further key findings from the report suggest:

  • Systems and parts product segment led the market in 2018 and is anticipated to grow at a lucrative rate over the forecast period
  • CAD/CAM sub-segment of systems and parts accounted for the largest market share in terms of revenue in 2018, owing to technological advancements
  • North America led the dental equipment market in 2018 with a revenue share of USD 1.84 billion owing to the presence of advanced healthcare facilities and strong reimbursement scenarios
  • Some of the key players operating in the market are, Cook Medical; Smiths Medical; Edwards Life Sciences Corporation; Medtronic Inc.; and Johnson & Johnson.

Molecular Diagnostics Market Worth $18.2 Billion By 2027

The global molecular diagnostics market size is expected to reach USD 18.2 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 9.0% over the forecast period. Increasing prevalence of infectious diseases such as influenza and human papillomavirus is projected to be the key factor the growth of the market.

In the underdeveloped regions of Africa, increasing instances of infections such as tuberculosis and HIV have been witnessed in the last few years. This is projected to drive the demand for accurate and early diagnostic techniques to curb the spread of these infections.

Rapid technological advancements-leading to accurate results, portability, and cost-effectiveness-are expected to be a high impact rendering driver for this market. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Companies such as Sigma Aldrich Corporation and Qiagen are developing a new range of molecular diagnostic techniques, such as Transcription-Mediated Amplification (TMA) and Loop-Mediated Isothermal Amplification (LAMP), for the diagnosis of tumors.

Key players in the market are adopting various marketing strategies such as collaborations with technologically advanced companies and diagnostic centers. Furthermore, players are focusing on expanding their geographic presence in order to increase their market share.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/molecular-diagnostics-market

Further key findings from the study suggest:

  • Reagents dominated the market in 2019 and is also projected to be the fastest-growing product segment owing to its high adoption in research and clinical settings. Standard reagents also provide efficient and accurate results
  • Instruments such as next generation sequencing platforms and PCR are increasingly preferred by diagnostic institutes and central laboratories as these tests deliver reliable and quick results and are suitable for a number of diagnostic procedures
  • Central laboratories emerged as the leading test location for molecular diagnostics in 2019. This is attributed to the availability of skilled labor and well-established infrastructure
  • Point-of-care is expected to be the fastest-growing segment over the forecast period owing to increase in demand for bedside testing, accuracy of results, and rise in healthcare awareness
  • Infectious diseases were the largest revenue generating segment in 2019 as molecular diagnostics offer clinicians with better substitutes to diagnose numerous infectious pathogens, bacteria, and virus in a short time while producing extremely accurate results
  • The oncology segment is projected to exhibit a CAGR of around 11.3% over the forecast period owing to increasing awareness amongst patients and healthcare professionals regarding available technologies such as molecular testing for cancer diagnosis
  • On the basis of technology, PCR was the largest revenue generating segment in 2019 owing to factors such as growing applications of multiplex PCR and commercialization of easy-to-use PCR-based molecular diagnostic kits
  • North America was the largest revenue generating region in 2019, followed by Europe. Key factors attributing to their dominance are high patient awareness levels, sophisticated healthcare infrastructure, growing healthcare expenditure, and high R&D pertaining to drug discovery and development
  • Some of the major players operating in molecular diagnostics market are F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Novartis AG (Grifols); Danaher Corporation; Alere, Inc.; Sysmex Corporation; bioMérieux SA; Becton, Dickinson and Company; Hologic, Inc. (Gen Probe); Johnson & Johnson Services, Inc.; Bayer AG; Cepheid; Dako; and Qiagen.

Vascular Closure Devices Market Size Worth $1.3 Billion By 2024

Global vascular closure devices market size is anticipated to reach USD 1.3 billion by 2024, according to a new report by Grand View Research, Inc. Growing popularity of femoral artery cardiac catheterization and high success rate of vascular closure device (VCDs) for improved patient comfort and shortening of hemostasis time are potential factors for the projected growth of VCDs market over the forecast period. Adoption of VCDs for diagnostic and therapeutic interventions that facilitate endovascular image-guided interventions to detect coronary heart disease are expected to contribute toward the growth of this market throughout the forecast period.

Male cardiologist gestures while discussing diagnosis with an unrecognizable female patient.

Moreover, ability of VCDs to overcome complications, such as prolonged bed rest and patient discomfort caused by manual compression, is expected to revolutionize the market growth over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/vascular-closure-device-vcd-market

Further Key Findings From the Report Suggest:

  • VCDs offer three types of products, which includes active approximators, passive approximators, and external hemostatic devices. Out of all three, active approximators dominated the market in 2015 as they shorten the time to ambulation and possess high efficiency rate.
  • Amongst the different end-users of VCDs, acute care facilities accounted for the largest share and are expected to maintain their dominant position over the forecast period. This is attributed to the rising popularity of VCDs in acute care treatment facilities.
  • Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the presence of unmet demands by the hospitals and rising R&D investment in this region.
  • Some key players operating in this industry include Cardinal Health; Abbott Laboratories; COOK; Medtronic; W L. Gore & Associates; Boston Scientific Corporation; Biotronik GMBH & CO.KG; TZ Medical, Inc.; C. R. Bard, Inc.; ST. JUDE MEDICAL; Cardiva Medical, Inc.; Merit Medical Systems, Inc.; ESSENTIAL MEDICAL, INC; and Scion BioMedical.
  • This market is expected to witness lucrative growth owing to high level of competitive rivalry, which translates to high revenue generation in this sector. These prominent players are opting for different strategies to boost their status in this market. Companies are involved in developing novel VCDs and in turn broaden their product portfolios. Acquisition and collaboration with small companies in order to enhance presence is also expected to propel growth in this vertical.
  • For instance, in October 2015, Cardinal Health acquired Johnson & Johnson’s Cordis business. Cordis is a leader in manufacturing and marketing of cardiology and endovascular devices. This acquisition was intended to expand Cardinal’s VCD product catalog to reinforce its status in the market.
  • North America dominated the vascular closure device market in 2015, with over 33% of total revenue. The presence of key players in this region, which are primarily involved in marketing and development of innovative VCDs, to facilitate cardiac surgeries can be attributed to the largest share of North America. Demand of products for monitoring of coronary artery disease is also expected to drive growth.

Latin America In Vitro Diagnostics Market Size To Reach $5.1 Billion By 2024

The latin america IVD market is expected to reach over USD 5.1 billion by 2024, according to a new report by Grand View Research, Inc. The Latin America IVD market is expected to grow at a significant CAGR till 2024 owing to the rising prevalence of target disorders, aging population, and the presence of favorable government initiatives for early disease diagnosis. Other factors that are anticipated to boost the growth include the introduction of technologically advanced instruments and the increasing R&D initiatives for the development of disease-specific kits.

Regular testing for diabetes, cardiovascular, cancer, and sexually transmitted diseases are necessary for the timely treatments, further avoiding the risk of fatal health complications. The availability of tests for home and near patient testing is estimated to further enhance the usage rates of these devices. From November 2015, the Anvisa, which is a regulatory body for medical devices in Brazil, has started allowing the registration for HIV self-testing kits.

The increasing adoption point of care devices coupled with the increasing awareness among the healthcare professionals regarding the early diagnosis of various diseases has provided a boost to the Latin IVD market. The rising epidemic of communicable diseases in the southernpart of Latin America, the growing need for rapid and accurate diagnostics, and the changing healthcare infrastructure scenario are some of the key drivers of the Latin IVD market.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/latin-america-in-vitro-diagnostics-ivd-market

Further key findings from the study suggest:

  • The instrument segment is one of the most important segments of in vitro diagnostics. The presence of highly automated analyzers and the availability of over the counter products are some of the factors responsible for its significant share.
  • The Molecular diagnostics segment is anticipated to be the fastest growing technology over the decade. Molecular diagnostics is a transformative area of diagnostics. The continuous innovation in technology helps the physicians for critical decision making
  • The infectious disease segment held the largest share in 2015 over 24% owing to the presence of favorable government initiatives in association with the WHO to curb communicable diseases.
  • The home care segment is estimated to witness a significant growth over the forecast period. The high number of R&D initiatives undertaken by key competitors for the development of portable IVD devices with improved sensitivity and user-friendliness is a key factor attributing towards its growth.
  • In 2015, Brazil was the largest regional segment with a revenue generation of over USD 1.2 billion owing to the established healthcare infrastructure, growing awareness for cancer screening, and the increasing demand for genetic testing.
  • Peru is expected to be one of the fastest growing regions on account of the growing economic stability, high unmet clinical needs, and the rising disposable incomes
  • Key players operating in the Latin America IVD market are Roche Diagnostics, Abbott Laboratories, Inc., Hologic (Gen-Probe), Becton Dickinson (BD) Company, Alere, Inc., Bio-Rad Laboratories, Qiagen N.V., Inc., bioMerieux, BioQuidel Corporation, and Siemens Healthcare.

Latin America ERP Software Market Size Worth $2.73 Billion By 2025

The Latin America ERP software market size is expected to reach USD 2.73 billion by 2025, according to a new report conducted by Grand View Research, Inc. ERP applications have helped many large-scale organizations to bring clarity and visibility into their business. With rapidly growing small and medium enterprises (SMEs) and the adoption of evolving technology demand in SMEs is expected to grow over the forecast period. Furthermore, rising awareness among small & medium enterprises (SMEs) and increasing need for business process efficiency and transparency aid the market growth over the forecast period.

SMEs have been facing various barriers to the adoption of this technology because of the expensive and less user-friendly nature of the software. Many SMEs in Brazil, Mexico, Chile, and Peru are still using old IT systems to operate their business. There is a growing need for the adoption of upcoming IT systems to sustain in the competitive market. enterprise resource planning software helps the operation of core business processes including sales & distribution, supply chain management, accounting, financial control, and HR, which is expected to propel demand from various SMEs.

The cloud deployment segment is expected to witness a significant growth rate, due to its growing adoption, although the on-premise deployment segment is anticipated to dominate the market (in terms of size) by 2025. Cloud-based applications reduce IT infrastructure costs leading to the adoption of cloud-based applications among enterprises. The investment in cloud-connected mobile applications has increased as mobile owing to the growing penetration of Bring Your Own Device (BYOD) among the organizations. The vendors are developing cloud-based solutions that can be accessed via mobile platforms such as tablets and smartphones expected to influence the Latin America ERP software market growth further.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/latin-america-enterprise-resource-planning-erp-software-market

Further key findings from the report suggest:

  • One of the major factors expediting market growth are the evolution of enterprise software and workplace automation industry practices in the Latin America marketplace.
  • Increasing investment in manufacturing coupled with rising demand for industry dedicated software is expected to propel growth over the forecast period.
  • Brazil region dominated the marketplace, accounting for the largest global market share (in terms of revenue) in 2016
  • In Mexico growth is driven by increasing vehicle and parts production particularly in the states of Aguascalientes, Guanajuato, and San Luis Potosi
  • The key industry participants include IBM (U.S.A.), Oracle (U.S.A.), Microsoft (U.S.A.), SAP SE (Germany), Infor (U.S.A.), and Sage Group Plc (U.K.).

Latin America Magnesium Nitrate Market Worth $113.5 Million By 2026

The Latin America magnesium nitrate market is projected to reach USD 113.5 million by 2026, according to a new report by Grand View Research, Inc. registering a 4.5% CAGR during the forecast period. Growing demand from fertilizers and explosives manufacturing industry is expected to drive market growth over the forecast period.

Magnesium nitrate is used as a catalyst for making explosives as it is a strong oxidizer and enhances the combustion of other substances that are utilized in the production of explosives. In the mining industry, explosives are used to extract the ore and discover ore-bodies. Latin America comprises of some of the largest and profitable mines, which is one of the prominent reasons for the robust growth of the mining industry. One of the largest mines of Latin America, Yonacoda gold mine, is situated in Peru and has been recognized as the second-largest open-pit gold mine in the world

Brazil is one of the fastest emerging economies in Latin America, with the chemical and agriculture sector as the backbone of a growing economy. The ability of magnesium nitrate to function as a stabilizer and preservative is likely to increase its utilization in the chemical industry. In addition, with a total arable land availability of 329 million hectares, the country designated 24.3% of the land to produce perennial crops and 52.1% for pastures.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/latin-america-magnesium-nitrate-market

Further key findings from the report suggest:

  • The additive segment accounted for the largest market share of 64.0 %, in terms of volume, in 2018 owing to the increase in consumption of fertilizers in agriculture sectors
  • Nitric acid application is expected to grow at a CAGR of 3.7% from 2019 to 2026 owing to rising demand in the production of explosives and fertilizers
  • Chile is the fastest growing country with a CAGR of 4.6%, in terms of volume, on account of increased mining activities in the region, particularly due to the government regulations encouraging controlled mining in order to boost economy
  • Mexico dominated the Latin America magnesium nitrate market with a volume share of 21.1% in 2018 due to growth in consumption of synthetic fertilizers and flourishing mining sector
  • Some of the key industry participants are Avantor Performance Materials, Haifa Mexico, Sigma Aldrich, American Elements, Van Iperen International, Yara International, Neochim PLC, AKO Kasei Co. Ltd., and Rongyu Chemical Co. Ltd.

CSA Food Safety Testing Market Size Worth $1.36 Billion By 2025

The Central & South America food safety testing market size is expected to reach USD 1.36 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 5.7% during the forecast period. Increasing food safety concerns due to consumer preference for processed and packaged eatables are expected to contribute to the market growth in the region. Moreover, rising demand for exotic vegetables and fruits, premium coffee, and imported products continue to contribute to safety concerns. This is projected to augment the market growth.

Changing lifestyle and increased per capita income have resulted in high demand for packaged and ready-to-eat products, which is also likely to boost market growth. Manufacturers are taking increasing efforts to ensure food safety owing to economic losses caused by foodborne diseases. Foodborne disease outbreak is a major cause of diarrheal diseases and poses a significant threat in the majority of the Central & South American countries. Such diseases cause severe and long-lasting damages including ulceration, meningitis, chronic diseases affecting articular and respiratory system. This is expected to have a positive impact on the market expansion. In addition, rising awareness levels among consumers regarding safety will also contribute to the market development in the years to come.

Furthermore, regional governments have launched initiatives, such as Good Farming Practice (GFP) and Good Manufacturing Practice (GMP) to ensure safety. Safety testing service providers have their own laboratories that offer various services including microbiological, allergen, Genetically Modified Organisms (GMO), nutritional analysis, and residue and contamination testing. In addition, vegetables and fruits producers perform routine tests by using test kits to check their products for any contamination. Meat, poultry, and seafood is the largest application segment, followed by processed eatables. Increased exports of cocoa from tropical countries and quinoa from Bolivia is estimated to boost the market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/central-south-america-food-safety-testing-market

Further key findings from the study suggest:

  • Microbiological testing segment accounted for 43.1% of the total revenue share in 2017 as this testing focuses on the detection and enumeration of microorganisms using biological, biochemical, molecular, or chemical methods
  • GMO testing segment is projected to expand at a CAGR of 5.8% during the forecast years due to strict regulations regarding the cultivation of GMO seeds and rising instances of illegal GMO crops cultivation in the region
  • Meat, poultry, and seafood end-use segment accounted for a significant share of the market in 2017 as these products require testing on a regular basis for their microbiological quality as well as for the presence of chemical constituents
  • Market in Peru is expected to register a strong CAGR owing to rise in disease outbreaks in the country along with increased government regulations to ensure food safety
  • The market is highly concentrated with a few number of companies accounting for large market share along with the presence of numerous small-scale firms providing specialized services to food sector across the value chain